Found: 4
Select item for more details and to access through your institution.
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
- Published in:
- Diabetologia, 2023, v. 66, n. 8, p. 1413, doi. 10.1007/s00125-023-05921-8
- By:
- Publication type:
- Article
Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 331, doi. 10.1111/dom.14871
- By:
- Publication type:
- Article
Abstract 157: Comparable total exposure of once-weekly insulin icodec between different subcutaneous injection regions.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2022, v. 26, p. 67, doi. 10.4103/2230-8210.363662
- By:
- Publication type:
- Article
Abstract 133: Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin Icodec vs. once-daily insulin glargine in T2D.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2022, v. 26, p. 57, doi. 10.4103/2230-8210.363637
- By:
- Publication type:
- Article